Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (271-280 of 494) with videos related to

Pageof 50
Sort By:
The Journal of Trauma and Acute Care Surgery|March 26, 2014
A community traffic safety analysis of pedestrian and bicyclist injuries based on the catchment area of a trauma centerDekeya R Slaughter, Nick Williams, Stephen P Wall, et al.
Scientific Reports|March 30, 2026
Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinomaFiete Gehrisch, Kiara A Schmid, Martina Kluth, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Experimental and Molecular Pathology|March 22, 2015
HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancerChristoph Burdelski, Oliver M Ruge, Nathaniel Melling, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
Oncotarget|February 2, 2017
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Pageof 50

Showing results (271-280 of 494) with videos related to

Sort By:
Pageof 50
The Journal of Trauma and Acute Care Surgery|March 26, 2014
A community traffic safety analysis of pedestrian and bicyclist injuries based on the catchment area of a trauma centerDekeya R Slaughter, Nick Williams, Stephen P Wall, et al.
Scientific Reports|March 30, 2026
Low E-cadherin expression is associated with poor prognosis in pulmonal adenocarcinomaFiete Gehrisch, Kiara A Schmid, Martina Kluth, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancerAlexander T El Gammal, Michael Brüchmann, Jozef Zustin, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Experimental and Molecular Pathology|March 22, 2015
HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancerChristoph Burdelski, Oliver M Ruge, Nathaniel Melling, et al.
Human Pathology|November 29, 2015
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrenceAlexandra Pust, Dominik Kylies, Claudia Hube-Magg, et al.
Oncotarget|February 2, 2017
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Pageof 50